Dr. Sophie Martucci is an expert in Public Health from the School of Life Sciences at the University of Warwick. As part of her agents of infectious disease module and science communication model, she covers the MMR Vaccine ...
Jan 19, 2024
0
0
A feral kitten in Omaha, Nebraska, tested positive for rabies in November 2023. It died of the raccoon variant of the virus, which is typically found only in the Appalachian Mountains. Detecting this variant hundreds of miles ...
Jan 9, 2024
0
0
As Ghana and Nigeria grapple with outbreaks of anthrax, scientists say governments must prioritize funds for vaccination to prevent a re-emergence of the disease across West Africa.
Aug 18, 2023
0
4
Researchers at the University of Basel have developed a new approach for a vaccine against COVID-19. This vaccine is based on a modified coronavirus that can enter body cells and trigger an effective immune response but cannot ...
May 22, 2023
0
53
In the U.S., the bacterium Klebsiella pneumoniae is a common cause of urinary tract infection, bloodstream infection and pneumonia. While infections with the bacterium can be easily treated in some, Klebsiella has a dangerous ...
May 19, 2023
0
46
The lifting of international emergency status for COVID-19 could pose serious challenges for global South countries in managing the virus, health experts caution.
May 15, 2023
0
2
Getting vaccines to people who need them isn't always easy. Many vaccines require cold storage, making it difficult to ship them to remote areas that don't have the necessary infrastructure.
Apr 24, 2023
0
37
Africa's first mRNA vaccine hub was ceremonially launched on Thursday to acclaim from the UN's global health chief, who hailed it as a historic shift to help poor countries gain access to life-saving jabs.
Apr 20, 2023
0
2
Memory B cells play a critical role to provide long-term immunity after a vaccination or infection. In a study published in the journal Immunity, researchers describe a distinct and novel subset of memory B cells that predict ...
Mar 22, 2023
0
63
Medicines that are based on mRNAs and proteins—particularly vaccines and antibodies—are time-intensive and costly to make. The challenge is in producing the necessary mRNAs and proteins in large enough amounts at low ...
Feb 22, 2023
0
39
